Log in to save to my catalogue

Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with...

Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3d28b525f6f24d7184345836b258f2cb

Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

About this item

Full title

Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

Publisher

United States: John Wiley and Sons Inc

Journal title

HemaSphere, 2024-08, Vol.8 (8), p.e129-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley and Sons Inc

Subjects

Subjects and topics

More information

Alternative Titles

Full title

Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3d28b525f6f24d7184345836b258f2cb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3d28b525f6f24d7184345836b258f2cb

Other Identifiers

ISSN

2572-9241

E-ISSN

2572-9241

DOI

10.1002/hem3.129

How to access this item